BRGX
Bioregenx, Inc.
$0.01
+0.00 (+0.00%)
At close · Jul 3
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern. As reflected in the accompanying financial statements, for the three months ended March 31, 2026, the Company incurred a net loss of $(26,415), generated cash from operations of $26,629 and had a stockholder’s deficit of $4,533,316 as of that date. At March 31, 2026, the Company had cash on hand in the amount of $45,806. In addition, notes payable of $522,500 are in default. As a result, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 20, 2026
Market Cap
$7.38M
Shares
971,575,183
Options Calculator
Theoretical estimateEstimate what a long-dated option on BRGX could return if you hold it and the stock reaches a target price. Premiums are theoretical Black-Scholes-Merton values — tune the inputs to match your broker, then compare each strike's return against simply holding the shares.
Best strike
—
Highest estimated return
Return at target
—
— annualized
Breakeven
—
Stock price to break even
Hold the stock
—
— annualized, with dividends
Return by strike at your target price
Strike ladder
| Strike | Moneyness | Premium | Breakeven | Value at target | Return | Annualized | Max loss |
|---|
Per share; one contract = 100 shares. Premiums are theoretical Black-Scholes-Merton estimates — real options are American-style and priced off an implied-volatility smile, so use your broker's quote for the actual premium. Not investment advice.